Data from major clinical trials such as the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Study; the European Randomized Study of Screening for Prostate Cancer; the Göteborg prostate cancer screening trial; and the Cluster Randomized Trial of PSA Testing for Prostate Cancer generated controversial conclusions (13-17). The gene discussed is KLK3; the disease is Familial prostate cancer.